MyFinsight
Home
Blog
About
Contact
Maturities of marketable
securities
$55,000K
Proceeds from exercise of
warrants
$123K
Proceeds from espp
purchases
$121K
Proceeds from exercise of
stock options
$56K
Net cash provided by
investing activities
$54,898K
Net cash provided by
financing activities
$300K
Canceled cashflow
$102K
Net increase
(decrease) in cash, cash...
$25,305K
Canceled cashflow
$29,893K
Purchases of property and
equipment
$102K
Stock-based compensation
expense
$3,824K
Prepaid expenses and
other assets
-$1,727K
Accounts payable
$1,024K
Non-cash lease expense
$412K
Depreciation expense
$274K
Net cash used in
operating activities
-$29,893K
Canceled cashflow
$7,261K
Net loss
-$33,685K
Accrued expenses and
other liabilities
-$2,745K
Operating lease
liabilities
-$386K
Accretion income on
marketable securities
$292K
Other long-term
assets
$46K
Back
Back
Cash Flow
Aura Biosciences, Inc. (AURA)
Aura Biosciences, Inc. (AURA)
source: myfinsight.com